News and Publications

Categories

ARCHIMEDlife News

  • amedes and ARCHIMEDlife – a new strong international alliance

    ARCHIMEDlife News January 17, 2020
    ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and medical-diagnostic services for patients, physicians and… Read more

  • SSIEM 2019 in Rotterdam

    ARCHIMEDlife News August 27, 2019
    Exciting! Our booth with a brand new look and novel, innovative portfolio of diagnostic tests and services. First time presenting at SSIEM, 3 – 6… Read more

  • New cut-offs for lysosomal enzyme activities.

    ARCHIMEDlife News June 6, 2019
    We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal enzyme activities from Dried Blood Spots… Read more

  • Improving our ability to diagnose Hemoglobinopathies.

    ARCHIMEDlife News October 1, 2018

    Results of a prospective study using High-Resolution Mass Spectrometry. The goal of our study, in cooperation with the University Medical Center Hamburg in Eppendorf Germany,… Read more

  • First LEA assay launched

    ARCHIMEDlife News March 14, 2018
    LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses (MPS) can be diagnosed from one… Read more

  • Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

    ARCHIMEDlife News March 7, 2018
    The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients, otherwise women at risk might be… Read more